APP下载

羟苯磺酸钙治疗非增生性糖尿病视网膜病变

2021-08-18胡一川

中国现代医生 2021年19期
关键词:阿卡波糖糖尿病视网膜病变二甲双胍

胡一川

[關键词] 非增生性;糖尿病视网膜病变;羟苯磺酸钙;阿卡波糖;二甲双胍

[中图分类号] R587.1          [文献标识码] A          [文章编号] 1673-9701(2021)19-0018-04

Efficacy of calcium dobesilate in the treatment of non-proliferative diabetic retinopathy

HU Yichuan

Department of Endocrinology, the Affiliated Shuyang Hospital of Xuzhou Medical University(Shuyang People′s Hospital), Shuyang   223600, China

[Abstract] Objective To observe the clinical efficacy of calcium dobesilate in the treatment of non-proliferative diabetic retinopathy (NPDR). Methods Sixty-four NPDR patients admitted to our hospital from January 2018 to April 2020 were selected. They were randomly divided into the observation group and the control group, with 32 cases in each group. Patients in the control group were given basic treatment, while patients in the observation group were given calcium dobesilate and basic treatment. The clinical efficacy of the two groups after treatment was evaluated. The blood glucose of the two groups before and after treatment was detected. The visual acuity, the number of microhemangioma, the area of bleeding spots and the thickness of macula were detected before and after treatment. The adverse reactions (ADRs) of the two groups were observed. Results ①The total effective rate of the observation group was 93.75%(30/32), which was significantly higher than that of the control group (71.88%, 23/32)(P<0.05). ②There were no statistically significant differences in the levels of fasting blood glucose, 2 hour postprandial blood glucose and glycosylated hemoglobin between the two groups before and after treatment (P>0.05).③Before treatment, there were no statistically significant differences in the visual acuity,the number of microhemangioma, the area of bleeding spots and the thickness of macula between the two groups(P>0.05).After treatment, the visual acuity,the number of microhemangioma, the area of bleeding spots and the thickness of macula in the two groups were significantly improved compared with those before treatment, the visual acuity in the observation group was higher than that in the control group,the number of microvessels,the area of bleeding spots and the thickness of macula in the observation group was less than that in the control group(P<0.05).④There was no significant difference in the incidence of ADRs between the two groups [15.62% (5/32) vs. 12.50% (4/32)](P>0.05). Conclusion Calcium dobesilate can improve NPDR and improve clinical efficacy, which is worthy of popularization and application.

猜你喜欢

阿卡波糖糖尿病视网膜病变二甲双胍
探讨二甲双胍治疗老年社区糖尿病的疗效
二甲双胍+克罗米芬治疗多囊卵巢综合征合并不孕的效果研究
糖尿病视网膜病变行玻璃体切除术的围术期护理体会
二甲双胍治疗喹硫平致精神分裂症患者糖脂代谢紊乱的研究
糖尿病视网膜病变玻璃体切除术后眼压变化的规律性临床研究
二甲双胍治疗糖尿病67例的疗效观察及对同型半胱氨酸及甲基丙二酸水平的影响
阿卡波糖或阿格列汀联合甘精胰岛素治疗2型糖尿病患者的对比研究
阿卡波糖联合维格列汀对老年2型糖尿病的治疗作用分析
糖尿病视网膜增殖膜应用抗VEGF因子后组织病理学研究
沙格列汀联合阿卡波糖治疗初诊老年2型糖尿病的效果观察